- Home
- MYNZ vs CVKD Comparison
MYNZ vs CVKD Comparison
Compare MYNZ & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- CVKD
- Stock Information
- Founded
- MYNZ 2021
- CVKD 2022
- Country
- MYNZ Germany
- CVKD United States
- Employees
- MYNZ N/A
- CVKD N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- MYNZ Health Care
- CVKD Health Care
- Exchange
- MYNZ Nasdaq
- CVKD Nasdaq
- Market Cap
- MYNZ N/A
- CVKD 17.1M
- IPO Year
- MYNZ 2021
- CVKD 2023
- Fundamental
- Price
- MYNZ $0.31
- CVKD $14.45
- Analyst Decision
- MYNZ Buy
- CVKD Strong Buy
- Analyst Count
- MYNZ 2
- CVKD 2
- Target Price
- MYNZ $3.00
- CVKD $52.50
- AVG Volume (30 Days)
- MYNZ 2.3M
- CVKD 59.6K
- Earning Date
- MYNZ 11-14-2024
- CVKD 11-08-2024
- Dividend Yield
- MYNZ N/A
- CVKD N/A
- EPS Growth
- MYNZ N/A
- CVKD N/A
- EPS
- MYNZ N/A
- CVKD N/A
- Revenue
- MYNZ $917,203.00
- CVKD N/A
- Revenue This Year
- MYNZ $36.69
- CVKD N/A
- Revenue Next Year
- MYNZ $91.67
- CVKD N/A
- P/E Ratio
- MYNZ N/A
- CVKD N/A
- Revenue Growth
- MYNZ 16.23
- CVKD N/A
- 52 Week Low
- MYNZ $0.19
- CVKD $5.40
- 52 Week High
- MYNZ $3.39
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- MYNZ 51.63
- CVKD 56.80
- Support Level
- MYNZ $0.28
- CVKD $11.19
- Resistance Level
- MYNZ $0.33
- CVKD $17.95
- Average True Range (ATR)
- MYNZ 0.05
- CVKD 1.37
- MACD
- MYNZ 0.00
- CVKD 0.10
- Stochastic Oscillator
- MYNZ 42.69
- CVKD 49.64
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.